Pink SheetTwo of the US FDA’s latest new product approvals, Santen Pharmaceutical Co., Ltd. ’s Omlonti and Fennec Pharmaceuticals Inc. ’s Pedmark, both overcame manufacturing-related complete response letters
ScripWhen asked to sum up what Santen Pharmaceutical Co., Ltd. sees as its broad health mission, the Japanese ophthalmology company’s president and CEO does not hesitate. “There is a global focus on eye
ScripThree-year-old US prescription eye care business Eyevance Pharmaceuticals LLC. has been acquired by Japan’s Santen Pharmaceutical Co., Ltd. , which gains a curated portfolio of commercialized produ
ScripWhile start-up company financings increased from nearly $2.2bn in the third quarter to $3bn in the fourth quarter, mergers and acquisitions involving young biopharmaceutical companies declined from a